MSD
The Development and Commercialization Team (DCT) leader directs CMC strategy and delivery for the company’s biologics portfolio, overseeing integrated development through commercialization. This senior leadership role partners with governance and cross-functional stakeholders to align technical, regulatory, and supply objectives. The position requires deep large-molecule CMC expertise and experience navigating global regulatory environments.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago
Director, CMC Product Development – Biologics
Beeline Medicines
Vice President, Biologics Process Development
Ipsen
CMC Lead
BeOne Medicines
Regulatory Affairs Consultant, CMC – Biologics
Parexel
Director, Technical Operations (Biologics CMC Technical Writing)
Travere Therapeutics
CMC Specialist with GMP Biologics Manufacturing Expertise
ASTARPRD